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Localized protein expression is crucial for the health and survival of axons and dendrites in a rapidly changing 
environment. This process, however, cannot take place without the precise spatiotemporal localization of the 
cellular translational machinery and of mRNA. mRNA transport and localization requires a variety of 
RNA-binding proteins. Here, we highlight a recent publication which presents evidence for the altered 
localization of the dsRNA-binding protein Staufen1 as a result of Amyotrophic Lateral Sclerosis (ALS) - linked 
mutations, supporting the perception of ALS as a RNA spatiotemporal mislocalization disease. 
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Neurons maintain broad inter-cellular communication 
networks by extending dendrites and axons over long 
distances. However, this highly polarized morphology poses 
a challenge for intra-cellular communication. Thus, the 
neuron requires tightly regulated mechanisms of cellular 
transport, signal transduction and localized protein synthesis. 
A recent publication revealed a possible role for the 
RNA-binding protein Staufen1 in Amyotrophic Lateral 
Sclerosis (ALS), demonstrating both in vitro and in vivo 
alterations in its localization to the synapse [1]. 
The correct spatiotemporal localization of local protein 
synthesis is essential for a neuron’s health and facilitates the 
neuron’s ability to respond to external stimuli in a precise 
spatial and temporal manner. It is a highly regulated event 
that requires the coordination of different processes including 
the transport, targeting, anchoring, and on-site translation of 
mRNA [2]. 
Alterations in RNA localization and local synthesis have 
been associated with neurodegenerative diseases such as 
Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular 
Atrophy (SMA), Huntington’s disease (HD) and others [3, 4]. 
ALS is a progressive neurodegenerative disease that affects 
both upper and lower motor neurons, resulting in a 
phenotype of muscle atrophy that eventually leads to death. 
Research over the past several years has pointed to a growing 
role for RNA metabolism and intracellular transport in ALS, 
with the association of RNA binding proteins TDP-43 and 
FUS/TLS, whose cellular pathology include aggregation into 
cytoplasmic inclusions [5] with the disease. C9ORF72, the 
most prevalent genetic cause for ALS, is not an 
RNA-binding protein, but its pathology includes RNA foci, 
aggregates that include both RNA and RNA-binding proteins 
and hinder RNA splicing, and disrupted nucleocytoplasmic 
transport [6-8].  
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The subcellular localization of mRNAs in eukaryotic cells 
requires the coordination of different processes including the 
transport, targeting, anchoring, and on-site translation of 
mRNA2; these are facilitated in great part by RNA-binding 
proteins (RBPs) that transport and anchor mRNAs as part of 
a RNA-protein (RNP) complex. The RBPs that bind to the 
mRNA have an additional role in maintaining the 
translationally repressed state, until the arrival of a triggering 
signal – such as a guidance cue, or injury [9-11]. This provides 
both spatial and temporal control [2, 3, 9, 12, 13]. RBPs recognize 
and bind mRNAs based on primary sequences, i.e. a 
consensus “zip code” sequence, or secondary sequences in 
the mRNA that target them for transport into subcellular 
compartments [14].  
The cytoskeleton “highways” and motor protein 
“vehicles” are fundamental in maintaining axonal transport, 
whose dysfunction has been linked to various 
neurodegenerative diseases. Indeed, perturbations of the 
retrograde transporting dynein complex are sufficient in 
causing mild, late-onset neurodegeneration [15]. However, 
beyond general slowing and disturbance in both anterograde 
and retrograde transport, the nature of transport can hold 
valuable information as to how transport can contribute to 
the development and progression of neurodegeneration. For 
example, the retrograde transport of pro-survival 
neurotrophic factors to the cell body is significantly inhibited 
in ALS model mice, and replaced with stress-related factors 
[16]. Altogether, this mislocalization renders the axon far 
more vulnerable to environmental stress [16]. Moreover, the 
same perturbations which cause mild neurodegeneration in 
healthy mice have an attenuating effect on disease 
progression in mSOD1 mice [17], further stressing the role of 
the transported cargo in axonal health.  
With this in mind, Gershoni-Emek et al. sought to identify 
proteins whose interaction with the retrograde transport 
motor protein dynein in synaptic fractions may be altered as 
a result of the ALS-linked mutation mSOD1G93A [1]. Mass 
spectrometry (MS) of dynein-immunoprecipitated complexes 
was complemented with bioinformatics network 
reconstruction using the Advanced Network Analysis Tool 
(ANAT) [18], and this highlighted a predicted role for 
dsRNA-binding protein Staufen1 as a central node in dynein 
Figure 1. Suggested model: Dynein switches between a trafficking role and an 
anchoring one as a result of ALS-linked mutations. In the healthy neuron, dynein serves 
to anchor the Staufen1-mRNA complex to a precise synaptic location, possibly enabling local 
synthesis of the tethered mRNA. In the diseased neuron, the Staufen1-RNA complex 
detaches from the synapse and is actively transported retrogradely by dynein away from the 
synapse. The switch between anchor and motor may be a result of the phosphorylative state 
of dynein. This depletion of Staufen1 and mRNA is suggested to increase the neurite’s 
susceptibility to environmental stressors, and to lead to neurodegeneration. 
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interactions with the predicted proteins EIF2AK2 (eukaryotic 
translation initiation factor kinase), PABPC1 (poly 
(A)-binding protein C) and PPP1CA (protein phosphatase A, 
catalytic subunit C), all of which play a part in the regulation 
of gene expression, suggesting a role for dynein-bound 
Staufen1 complexes in translational regulation of local 
expression. One of the proteins identified by MS uniquely in 
the mSOD1 sample was Protein Phosphatase 1, catalytic 
subunit β (PP1B), which was predicted to interact with 
Staufen1 via PP1A. Dynein motility can be modulated by its 
phosphorylation state [19], and PP1B has been shown to 
dephosphorylate cytoplasmic dynein, suggesting it to switch 
dynein between a trafficking and an anchoring mode [20,21]. 
The predicted interaction of Staufen1 and PP1B with 
dynein was subsequently demonstrated in vivo and in vitro, 
and the effect of ALS-linked mutations on their synaptic 
localization and interaction with dynein was studied. A 
decreased synaptic localization of both Staufen1 and PP1B as 
a result of the ALS-linked mutations mSOD1G93A and 
TDP43A315T in vitro was shown, together with a depletion of 
Staufen1 from the neuromuscular junction (NMJ) in vivo in 
the mSOD1G93A mouse model. 
Taken together, Gershoni-Emek et al. suggest a model in 
which under physiological conditions dynein anchors 
Staufen1 together with its bound mRNAs to a precise 
synaptic location, consistent with a previously described 
tethering role for dynein in maintaining synaptic stability [22]. 
This anchored RNA complex at a distinct place provides the 
neuron the ability to respond to alterations in its 
microenvironment. As a result of ALS-linked mutations, 
dynein switches to a trafficking mode, clearing Staufen1 and 
its bound mRNAs from the NMJ, resulting in an increased 
vulnerability of the neuron to stress.  
Staufen1 has a well-described role in spatiotemporal 
localization of mRNA in the D. melanogaster oocyte [23, 24], 
as well as in the formation, transport and anchoring of RNA 
granules in neurons [24, 25]. Staufen1 has been linked to 
numerous neuronal functions, among them neuronal 
plasticity during memory formation [26, 27], as the 
dendritically localized mRNA CamKIIa whose translation is 
activity-dependent, can be found in Staufen1 mRNPs [28]. 
Within neuronal Staufen1 mRNP granules, translational 
repression has recently been suggested to be maintained by 
the inclusion of inhibitory microRNAs together with their 
mRNA targets [29]. In this context, anchoring may be an 
essential step preceding the release from translational 
repression. 
Although Staufen localization in muscles and at the NMJ 
has been previously described [30, 31], Gershoni-Emek and 
colleagues are the first to show alterations in Staufen1 as a 
result of ALS. Previous works have reported an association 
between TDP-43 and Staufen1, suggesting a role for TDP-43 
in shuttling of mRNA between mRNP granules [32]. 
Moreover, an activation-regulated, functionally coordinated 
complex of TDP-43, Staufen1 and FMRP (Fragile X-related 
Mental Retardation Protein) has been shown to play a role in 
neuroprotection [33, 34].  
In order to further examine the role of Staufen1 in axonal 
health and ALS-related neurodegeneration, it would be 
beneficial to characterize the milieu of Staufen1-bound 
mRNAs in axons, and to probe how the spatiotemporal 
localization of these mRNAs is altered as a result of ALS. 
Additionally, it would be interesting to understand how 
Staufen1 is trafficked and localized, and whether it interacts 
directly with dynein. 
  In summary, recent work supports the concept of 
spatiotemporal mislocalization in neurodegeneration [3], and 
provides an exciting new avenue to explore in understanding 
ALS pathology.  
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